Spotlight on Formulary Management
ACPE UAN: 0233-0000-19-018-L01-P | Contact Hours: 1.25 | Activity Type: Knowledge-based
The treatment of hemophilia has evolved from a one-size-fits-all approach to a highly individualized care approach, and it continues to become more patient-centered and specific. This is especially important given that new therapies being introduced have mechanisms of action other than simple factor replacement. Additionally, hemophilia therapies continue to receive approval and enter the market, but what impact do these pipeline therapies have on the standards of care? What strategies can payers implement to manage costs, while also meeting the needs of the patients?
Join this session to discover emerging hemophilia therapies and hemophilia management strategies. This session will also discuss the value of collaboration between payers and patient groups.
At the completion of this activity, participants should be able to: